NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021-Reference-Cited by-同舟云学术

NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021

Published:2021-01-06 Issue:1 Volume:19 Page:16-27
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Pollyea Daniel A.¹,Bixby Dale²,Perl Alexander³,Bhatt Vijaya Raj⁴,Altman Jessica K.⁵,Appelbaum Frederick R.⁶,de Lima Marcos⁷,Fathi Amir T.⁸,Foran James M.⁹,Gojo Ivana¹⁰,Hall Aric C.¹¹,Jacoby Meagan¹²,Lancet Jeffrey¹³,Mannis Gabriel¹⁴,Marcucci Guido¹⁵,Martin Michael G.¹⁶,Mims Alice¹⁷,Neff Jadee¹⁸,Nejati Reza¹⁹,Olin Rebecca²⁰,Percival Mary-Elizabeth⁶,Prebet Thomas²¹,Przespolewski Amanda²²,Rao Dinesh²³,Ravandi-Kashani Farhad²⁴,Shami Paul J.²⁵,Stone Richard M.²⁶,Strickland Stephen A.²⁷,Sweet Kendra¹³,Vachhani Pankit²⁸,Wieduwilt Matthew²⁹,Gregory Kristina M.³⁰,Ogba Ndiya³⁰,Tallman Martin S.³¹

Affiliation:

1. 1University of Colorado Cancer Center;

2. 2University of Michigan Rogel Cancer Center;

3. 3Abramson Cancer Center at the University of Pennsylvania;

4. 4Fred & Pamela Buffett Cancer Center;

5. 5Robert H. Lurie Comprehensive Cancer Center of Northwestern University;

6. 6Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;

7. 7Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;

8. 8Massachusetts General Hospital Cancer Center;

9. 9Mayo Clinic Cancer Center;

10. 10The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;

11. 11University of Wisconsin Carbone Cancer Center;

12. 12Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;

13. 13Moffitt Cancer Center;

14. 14Stanford Cancer Institute;

15. 15City of Hope National Medical Center;

16. 16St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center;

17. 17The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;

18. 18Duke Cancer Institute;

19. 19Fox Chase Cancer Center;

20. 20UCSF Helen Diller Family Comprehensive Cancer Center;

21. 21Yale Cancer Center/Smilow Cancer Hospital;

22. 22Roswell Park Comprehensive Cancer Center;

23. 23UCLA Jonsson Comprehensive Cancer Center;

24. 24The University of Texas MD Anderson Cancer Center;

25. 25Huntsman Cancer Institute at the University of Utah;

26. 26Dana-Farber/Brigham and Women’s Cancer Center;

27. 27Vanderbilt-Ingram Cancer Center;

28. 28O'Neal Comprehensive Cancer Center at UAB;

29. 29UC San Diego Moores Cancer Center;

30. 30National Comprehensive Cancer Network; and

31. 31Memorial Sloan Kettering Cancer Center.

Abstract

The NCCN Guidelines for Acute Myeloid Leukemia (AML) provide recommendations for the diagnosis and treatment of adults with AML based on clinical trials that have led to significant improvements in treatment, or have yielded new information regarding factors with prognostic importance, and are intended to aid physicians with clinical decision-making. These NCCN Guidelines Insights focus on recent select updates to the NCCN Guidelines, including familial genetic alterations in AML, postinduction or postremission treatment strategies in low-risk acute promyelocytic leukemia or favorable-risk AML, principles surrounding the use of venetoclax-based therapies, and considerations for patients who prefer not to receive blood transfusions during treatment.

Publisher

Harborside Press, LLC

Subject

Oncology

Link

https://jnccn.org/downloadpdf/journals/jnccn/19/1/article-p16.xml

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EV-mediated intercellular communication in AML: Transport of genetic materials in the bone marrow microenvironment;Experimental Hematology;2024-02

2. Acute Myeloid Leukemia Presenting as Common Colds: An Uncommon Consideration;Cureus;2024-01-30

3. The difference of double-positive T cells and double-negative-T cells in myeloid neoplasms before and after chemotherapy, and after COVID-19 infection;2024-01-19

4. Novel stratification for newly diagnosed acute myeloid leukaemia treated with venetoclax‐based therapy in the real world: Hokkaido Leukemia Net Study;British Journal of Haematology;2024-01-18

5. Therapeutic effect of allogeneic stem cell transplantation in acute myeloid leukemia patients with epigenetic modifier gene mutations;2024-01-11